Back
Simulations Plus 10K Form
Sell
40
SLP
Simulations Plus
Last Price:
27.47
Seasonality Move:
12.94%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-05 | 10Q | SLP/Simulations Plus Quarterly |
| 2024-01-05 | 10Q | SLP/Simulations Plus Quarterly |
| 2023-07-07 | 10Q | SLP/Simulations Plus Quarterly |
| 2023-04-07 | 10Q | SLP/Simulations Plus Quarterly |
| 2023-01-06 | 10Q | SLP/Simulations Plus Quarterly |
| 2022-07-08 | 10Q | SLP/Simulations Plus Quarterly |
Receive SLP News And Ratings
See the #1 stock for the next 7 days that we like better than SLP
SLP Financial Statistics
Sales & Book Value
| Annual Sales: | $70.01M |
|---|---|
| Cash Flow: | $941K |
| Price / Cash Flow: | 61.92 |
| Annual Sales: | $9.10 |
| Price / Book: | 3.02 |
Profitability
| EPS (TTM): | 0.49000 |
|---|---|
| Net Income (TTM): | $9.95M |
| Gross Margin: | $43.15M |
| Return on Equity: | 5.64% |
| Return on Assets: | 5.21% |
Simulations Plus Earnings Forecast
Key Simulations Plus Financial Ratios
- The Gross Profit Margin over the past 29 years for SLP is 61.63%.
- The Selling, General & Administrative Expenses for SLP have been equal to 44.66% of Gross Profit Margin.
- The Research & Development expenses have been 8.22% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of SLP is 14.22% of Total Revenues.
- Per Share Earnings over the last 29 years have been positive in 16 years.
Simulations Plus Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Technology |
| Sector: | Health Care |
| Current Symbol: | SLP |
| CUSIP: | 829214 |
| Website: | simulations-plus.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 3.26 |
| Quick Ratio: | 2.44 |
Price-to-Earnings
| Trailing P/E Ratio: | 56.1 |
|---|---|
| Forward P/E Ratio: | 28.05 |
SLP Technical Analysis vs Fundamental Analysis
Sell
40
Simulations Plus (SLP)
is a Sell
Is Simulations Plus a Buy or a Sell?
-
Simulations Plus stock is rated a Sell
The current Simulations Plus [SLP] share price is $27.49. The Score for SLP is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.